Acutely decompensated heart failure: Characteristics of hospitalized patients and opportunities to improve their care;Insuficiência cardíaca aguda: Características de uma população hospitalar e oportunidades para a melhoria dos cuidados prestados

Revista Portuguesa de Cardiologia

Volumn 25, Issue 1, 2006, Pages 13-27

  Moraes Sarmento, Pedro ^a   Fonseca, Cândida ^a   Marques, Filipa ^a   Ceia, Fátima ^a   Aleixo, Ana ^a  

^a NOVA MEDICAL SCHOOL   (Portugal)

Author keywords

Acute Heart failure; Co morbidity; Heart Failure Clinics; Hospitalization

Indexed keywords

ACUTE HEART FAILURE; ADULT; AGED; ANEMIA; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; EMERGENCY WARD; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORTALITY; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SCINTIANGIOGRAPHY; TEACHING HOSPITAL; URBAN AREA; VALVULAR HEART DISEASE;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 33645468001     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Reitsma J, Mosterd A, de Craen A, et al. Increase in hospital admission rates for heart failure in the Netherlands, 1980-1993. Heart 1996;76:388-92.
2. Ni H, Naumann D, Hershberger R. Analysis of trends in hospitalizations for heart failure. J Cardiac Fail 1999;5:79-84.
3. Stewart S, McIntyre K, MacLeod MM, Bailey AE, Capewell S, McMurray JJV. Trends in hospitalization for heart failure in Scotland 1990-1996. An epidemic that has reached its peak. Eur Heart J 2001;22:209-17.
4. Redfield MM, Jacobsen SJ, Burnett JC Jr., Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:294-202.
5. Stewart S, McIntyre K, Capewell S, McMurray JJV. An ageing population and heart failure: an increasing burden in the 21st century? Heart 2003;89:40-53.
6. McMurray JJV, Petrie M, Murdoch D, Davie A. Clinical epidemiology of heart failure: public and private health burden. Eur Heart J 1998;19(Suppl P):P9-16.
7. Tavazzi L. Epidemiological burden of heart failure. Heart 1998:79(Suppl S): S6-9.
8. Stewart S, Jenkins A, Buschan S et al. The current cost of heart failure in the UK - an economic analysis. Eur J Heart Fail 2002;4:361-71.
9. Nieminem MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005. Published ahead of print. doi:10.1093/eurheartj/ chi044.
10. Ceia F, Fonseca C, Mota T, Morais H, Matias F, de Sousa A, Gouveia-Oliveira A, on behalf of the EPICA Investigators. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail 2002;4:531-539.
11. Cleland JGF, Cohen-Solal A, Cosín Aguillar J, et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002;360:1631-1639.
12. Ceia F, Fonseca C, Azevedo I, Mota T, Morais H, Matias F, Costa C, et al., on behalf of the EPICA-RAM investigators. Epidemiology of heart failure in primary care in the Autonomous Region of Madeira: the EPICA-RAM study. Rev Port Cardiol 2005;24:173-189.
13. Fisher M, Baessler A, Hense HW, Hengstenberg C, Muscholl M, Homer S, et al. Prevalence of left ventricular diastolic dysfunction in the community: results from a Doppler echocardiographic-based survey of a population sample. Eur H J 2003;24:320-328.
14. Hogg K, Swedberg K, McMurray JJ. Heart failure with preserved systolic function: epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 2004;43:317-327.
15. Ferreira A, Fernando PM, Cortez M, Capucho R. Brandão F. Cerqueira-Gomes M. Epidemiologic aspects of congestive heart failure. Retrospective analysis of 2561 hospital admissions. Rev Port Cardiol 1996;15:395-410.
16. Ceia F, Fonseca C, Mota T, Morais H, Matias F, Costa C. Gouveia-Oliveira A, on behalf of the EPICA investigators. Epidemiology of heart failure in mainland Portugal: New data from the EPICA study. Rev Port Cardiol 2004;23(Suppl. III): 15-22.
17. Fonseca C, Morais H, Mota T, Matias F, Costa C, Gouveia-Oliveira A, Ceia F. The diagnosis of heart failure in primary care: value of symptoms and signs. Eur J Heart Fail 2004;6:795-800.
18. Wheeldon N, MacDonald T, Flucker CJ, McKendrick AD, McDweitt D, Stuthers AD. Chronic heart failure in the community: an echocardiographic study of its prevalence and an assessment of the workload it generates for primary health care and hospital physicians. Q J Med 1993;86:17-23.
19. Dahlström U. Frequent non-cardiac comorbidities in patients with chronic heart failure. Eur J Heart Fail 2005;7: 309-316.
20. Brown AM, Cleland JG. Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995. Eur Heart J 1998; 19:1063-1069.
21. Martinez-Sellés M, Robles JAG, Muñoz R, Serrano JA, Frades E, Muñoa MD et al. Pharmacological treatment in patients with heart failure: patients knowledge and occurrence of polypharmacy, alternative medicine and immunizations. Eur J Heart Fail 2004;6:219-226.
22. Ledwidge M, Travers B, Ryder M, Ryan E, McDonald K. Specialist care of heart failure improves appropriate pharmacotherapy at the expense of greater polypharmacy and drug-interactions. Eur J Heart Fail 2004;6:235-243.
23. Veehof L, Stewart R, Haaijer-Ruskamp F, Jong BM. The development of polypharmacy. A longitudinal study. Fam Pract June 2000;17:261-7.
24. Gustafsson F, Arnold JM. Heart failure clinics and outpatient management: review of the evidence and call for quality assurance. Eur Heart J 2004;25:1565-7.
25. Bocchi EA. Heart failure clinics: the Brazilian experience. Rev Port Cardiol 2004;Suppl 3:III47-55.
26. Fonarow GC. Heart failure disease management programs. Not a class effect. Circulation 2004;110:3506-3508.
27. Galbreath AD, Krasuski RA, Smith B, et al. Long-term health care and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation 2004;110:3518-3526.
28. Phillips CO, Wright SM, Kern DE, Singa RM, Shepperd S, Rubin HR. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure. JAMA 2004;291:1359-1367.
29. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology: W. J. Remme and K. Swedberg. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-1560.
30. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. Circulation 2001;104:2996-3007.
31. Ceia F, Fonseca C, Brito D, Madeira H. Heart failure treatment in Portuguese hospitals: results of a survey. Rev Port Cardiol 2001;20:1259-66.
32. Fonseca C, Ceia F, Brito D, Madeira H. How patients with heart failure are managed in Portugal. Eur J Heart Fail 2002; 4:563-566.
33. Cleland JGF, Swedberg K, Follath F, Komadja M, Cohen-Solal A, Aguilar JC et al. The EuroHeart failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442-463.
34. Ceia F, Fonseca C, Mota T, Morais H, Matias F, Costa C, Gouveia-Oliveira A. Aetiology, comorbidity and drug therapy of chronic heart failure in the real world: the EPICA substudy. Eur J Heart Fail 2004;6:801-806
35. Quiñones MA, Waggoner AD, Reduto LA, Nelson JG, Young JB, Winters, WL Jr. et al. A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 1981;744-53.
36. Dodge HT, Sandler H, Baxley WA, Hawley RR. Usefulness and limitations of radiographic methods for determining left ventricular volume. Am J Cardiol 1966;10:24.
37. Sandler H, Dodge HT. The use of single plane angiocardiograms for the calculation of left ventricular volume in man. Am Heart J 1968;325:34.
38. Imaging Guidelines for Nuclear Cardiology Procedures. American Society of Nuclear Cardiology. Equilibrium gated blood pool imaging protocols. J Nucl Cardiol 1996;26-9.
39. Henry WL, deMaria A, Gramiak R et al. Report of the American Society of Echocardiography Committee on nomenclature and standards in two-dimensional echocardiography. Circulation 1980;62:212-7.
40. Bonow RO, Carabello B, de Leon AC, Edmunds LH Jr., Fedderly BJ, Freed MD et al. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Heart Valve Dis 1998;672-677.
41. American Diabetes Association. Summary of revisions for the 2004 Clinical Practice Recommendations. Diabetes Care 2004;27:suppl. I.
42. Brito D, Pedro M, Metrass MJ, Pádua F, Madeira H. Heart failure: diastolic dysfunction vs. systolic dysfunction. Rev Port Cardiol 1995;14:741-4.
43. Martinez-Sellés M, Robles JAG, Prieto L, Serrano JA, Muñoz R, Frades E, Almendral J. Annual rates of admission and seasonal variations in hospitalizations for heart failure. Eur J Heart Fail 2002;4:779-786.
44. Grupo de Trabajo de Insuficiencia Cardiaca de la Sociedad Española de Medicina Interna. Heart failure in internal medicine departments. Med Clin (Barc) 2002;118:605-610.
45. Wright SP, Verouhis D, Gamble G, Swedberg K, Sharpe N, Doughty RN. Factors influencing the length of hospital stay of patients with heart failure. Eur J Heart Fail 2003;5: 201-209.
46. Di Lenarda A, Scherillo M, Maggioni AP, Acquarone N, Ambrosio GB, Annichiarico M, et al. Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds - the TEMISTOCLE study. Am Hear J 2003; 146: e12. doi:10.1016/s0002-8703(03)00315-6.
47. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993;22 (suppl A):6A-13A.
48. Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 2003;42:1226-1233.
49. Macedo ME, Lima MJ, Silva AO, Alcântara P, Carmona J. Prevalence, awareness, treatment and control of hypertension in Portugal. J Hypertension 2005.
50. J Hypertens 2005;23:1661-6.
51. Moraes-Sarmento P, Marques F, Fonseca C. Hipocoagulação oral na profilaxia do acidente tromboembólico: normas práticas de actuação. RFML 2002;7:287-97.
52. The sixth ACCP Consensus Conference on Antithrombotic Therapy. Chest 2001;119:194S-206S.
53. Ogren M, Bergqvist D, Eriksson H, Lindblad B, Sternby NH. Prevalence and risk of pulmonary embolism in patients with intracardiac thrombosis: a population-based study of 23 796 consecutive autopsies. Eur Heart J 2005;4 Feb. Epub-ahead-of-print.
54. Rosenow EC 3rd. Venous and pulmonary thromboembolism: an algorithmic approach to diagnosis and treatment. Mayo Clin Proc 2005;70:5067.
55. Van der Wal MHL, Jaarsma T, van Veldhuisen DJ. Non-compliance in patients with heart failure: how can we manage it? Eur J Heart Fail 2005;7:5-18.
56. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979;2:120-126.
57. Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol 2001;38:421-428.
58. De Groote P, Lamblin N, Mouquet F, Plichon N, McFadden E, Van Belle F, et al. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J 2004;25:256-62.
59. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12065 patients with new onset heart failure. Circulation 2003;197:223-225.
60. Maggioni AP, Opasich C, Anand I, et al. Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice. J Card Fail 2005;11: 91-98.
61. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borensten A. Anemia is associated with worse symptoms, greater impairment of functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-1786.
62. McCullough PA, Lepor NE. The deadly triangle of anemia, renal insufficiency, and cardiovascular disease: implications for prognosis and treatment. Rev Cardiovasc Med. 2005; 6:1-10.
63. Silverberg DS, Wexler D, Iaina A. The importance of anemia and its correction in the management of severe congestive heart failure. Eur J Heart Fail 2002;4:681-686.
64. Silverberg D, Wexler D, Blum M, Scwartz D, Iaina A. The association between congestive heart failure and chronic renal disease. Curr Opin Nephrol Hypertens 2004;13:163-70.
65. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: «Guyton revisited». Eur Heart J 2005;26:11-7.
66. McCullough PA, Hollander JE, Nowak RM, Storrow AB, Due P, Om T, et al. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med 2003;10:198-204.
67. Salpeter SR, Ormiston TM, Salpeter EE. Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. Ann Inern Med 2002;137:715-725.
68. Jones RC, Francis GS, Lauer MS. Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial. J Am Coll Cardiol 2004;44:1025-9.
69. Lenzen MJ, Scholte op Reimer WJM, Boersma E, Vantrimpont PJMJ, Follath F, Swedberg K, Cleland J, Komadja M. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 2004;25:1214-1220.
70. Fonarow GC, for the ADHERE Scientific Advisory Committee. Heart Failure Reviews 2004;9:179-185.